Cholesterol shuttling is important for RNA replication of coxsackievirus B3 and encephalomyocarditis virus

Cellular Microbiology

Volumn 17, Issue 8, 2015, Pages 1144-1156

  Albulescu, Lucian ^a   Wubbolts, Richard ^b   van Kuppeveld, Frank J M ^a   Strating, Jeroen R P M ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; HOST FACTOR; PHOSPHATIDYLINOSITOL 4 PHOSPHATE; VIRUS RNA;

ARTICLE; CELL ORGANELLE; CELL VIABILITY; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; COXSACKIEVIRUS B3; CYTOPLASM; ENCEPHALOMYOCARDITIS VIRUS; ENDOSOME; FEMALE; GENE REPLICATION; GENETIC TRANSFECTION; HELA CELL LINE; HOMEOSTASIS; HOST CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; INTRACELLULAR SPACE; MICROTUBULE ORGANIZING CENTER; NONHUMAN; PICORNAVIRUS INFECTION; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; UPREGULATION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS REPLICATION; CELL MEMBRANE; ENTEROVIRUS B; METABOLISM; PHYSIOLOGY; VIROLOGY;

ANIMALIA; CARDIOVIRUS; COXSACKIEVIRUS; ENCEPHALOMYOCARDITIS VIRUS; ENTEROVIRUS; PICORNAVIRIDAE; RNA VIRUSES;

CELL MEMBRANE; CHOLESTEROL; ENCEPHALOMYOCARDITIS VIRUS; ENTEROVIRUS B, HUMAN; HELA CELLS; HUMANS; ORGANELLES; RNA, VIRAL; VIRUS REPLICATION;

EID: 84937161875     PISSN: 14625814     EISSN: 14625822     Source Type: Journal    
DOI: 10.1111/cmi.12425     Document Type: Article

References (48)

1. Aminev, A.G., Amineva, S.P., and Palmenberg, A.C. (2003) Encephalomyocarditis viral protein 2A localizes to nucleoli and inhibits cap-dependent mRNA translation. Virus Res 95: 45-57.
2. Arita, M. (2014) Phosphatidylinositol-4 kinase III beta and oxysterol-binding protein accumulate unesterified cholesterol on poliovirus-induced membrane structure. Microbiol Immunol 58: 239-256.
3. Arita, M., Kojima, H., Nagano, T., Okabe, T., Wakita, T., and Shimizu, H. (2011) Phosphatidylinositol 4-kinase III beta is a target of enviroxime-like compounds for antipoliovirus activity. J Virol 85: 2364-2372.
4. Arita, M., Kojima, H., Nagano, T., Okabe, T., Wakita, T., and Shimizu, H. (2013) Oxysterol-binding protein family I is the target of minor enviroxime-like compounds. J Virol 87: 4252-4260.
5. Belov, G.A., and van Kuppeveld, F.J. (2012) (+)RNA viruses rewire cellular pathways to build replication organelles. Curr Opin Virol 2: 740-747.
6. Belov, G.A., Altan-Bonnet, N., Kovtunovych, G., Jackson, C.L., Lippincott-Schwartz, J., and Ehrenfeld, E. (2007) Hijacking components of the cellular secretory pathway for replication of poliovirus RNA. J Virol 81: 558-567.
7. Bolte, S., and Cordelieres, F.P. (2006) A guided tour into subcellular colocalization analysis in light microscopy. J Microsc 224: 213-232.
8. Cenedella, R.J. (2009) Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes. Lipids 44: 477-487.
9. Chen, H., Yang, J., Low, P.S., and Cheng, J.X. (2008) Cholesterol level regulates endosome motility via Rab proteins. Biophys J 94: 1508-1520.
10. Coyne, C.B., and Bergelson, J.M. (2006) Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 124: 119-131.
11. Danthi, P., and Chow, M. (2004) Cholesterol removal by methyl-beta-cyclodextrin inhibits poliovirus entry. J Virol 78: 33-41.
12. De Palma, A.M., Thibaut, H.J., van der Linden, L., Lanke, K., Heggermont, W., Ireland, S., etal. (2009) Mutations in the nonstructural protein 3A confer resistance to the novel enterovirus replication inhibitor TTP-8307. Antimicrob Agents Chemother 53: 1850-1857.
13. Dorobantu, C.M., van der Schaar, H.M., Ford, L.A., Strating, J.R., Ulferts, R., Fang, Y., etal. (2014) Recruitment of PI4KIIIbeta to coxsackievirus B3 replication organelles is independent of ACBD3, GBF1, and Arf1. J Virol 88: 2725-2736.
14. Eden, E.R., White, I.J., Tsapara, A., and Futter, C.E. (2010) Membrane contacts between endosomes and ER provide sites for PTP1B-epidermal growth factor receptor interaction. Nat Cell Biol 12: 267-272.
15. Gazina, E.V., Mackenzie, J.M., Gorrell, R.J., and Anderson, D.A. (2002) Differential requirements for COPI coats in formation of replication complexes among three genera of Picornaviridae. J Virol 76: 11113-11122.
16. Hato, S.V., Sorgeloos, F., Ricour, C., Zoll, J., Melchers, W.J., Michiels, T., and van Kuppeveld, F.J. (2010) Differential IFN-alpha/beta production suppressing capacities of the leader proteins of mengovirus and foot-and-mouth disease virus. Cell Microbiol 12: 310-317.
17. Honda, A., and Matsuzaki, Y. (2011) Cholesterol and chronic hepatitis C virus infection. Hepatol Res 41: 697-710.
18. Hsu, N.Y., Ilnytska, O., Belov, G., Santiana, M., Chen, Y.H., Takvorian, P.M., etal. (2010) Viral reorganization of the secretory pathway generates distinct organelles for RNA replication. Cell 141: 799-811.
19. Ikonen, E. (2008) Cellular cholesterol trafficking and compartmentalization. Nat Rev Mol Cell Biol 9: 125-138.
20. Ilnytska, O., Santiana, M., Hsu, N.Y., Du, W.L., Chen, Y.H., Viktorova, E.G., etal. (2013) Enteroviruses harness the cellular endocytic machinery to remodel the host cell cholesterol landscape for effective viral replication. Cell Host Microbe 14: 281-293.
21. Jiang, Z., Redfern, R.E., Isler, Y., Ross, A.H., and Gericke, A. (2014) Cholesterol stabilizes fluid phosphoinositide domains. Chem Phys Lipids 182: 52-61.
22. Keller, P., and Simons, K. (1998) Cholesterol is required for surface transport of influenza virus hemagglutinin. J Cell Biol 140: 1357-1367.
23. Lange, Y., Ye, J., Rigney, M., and Steck, T.L. (1999) Regulation of endoplasmic reticulum cholesterol by plasma membrane cholesterol. J Lipid Res 40: 2264-2270.
24. Lanke, K.H., van der Schaar, H.M., Belov, G.A., Feng, Q., Duijsings, D., Jackson, C.L., etal. (2009) GBF1, a guanine nucleotide exchange factor for Arf, is crucial for coxsackievirus B3 RNA replication. J Virol 83: 11940-11949.
25. Liscum, L., and Faust, J.R. (1989) The intracellular transport of low density lipoprotein-derived cholesterol is inhibited in Chinese hamster ovary cells cultured with 3-beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. J Biol Chem 264: 11796-11806.
26. Lloyd-Evans, E., Morgan, A.J., He, X., Smith, D.A., Elliot-Smith, E., Sillence, D.J., etal. (2008) Niemann-Pick disease type C1 is a sphingosine storage disease that causes deregulation of lysosomal calcium. Nat Med 14: 1247-1255.
27. Mackenzie, J.M., Khromykh, A.A., and Parton, R.G. (2007) Cholesterol manipulation by West Nile virus perturbs the cellular immune response. Cell Host Microbe 2: 229-239.
28. Maynell, L.A., Kirkegaard, K., and Klymkowsky, M.W. (1992) Inhibition of poliovirus RNA synthesis by brefeldin A. J Virol 66: 1985-1994.
29. Miller, S., and Krijnse-Locker, J. (2008) Modification of intracellular membrane structures for virus replication. Nat Rev Microbiol 6: 363-374.
30. Mukherjee, S., and Maxfield, F.R. (2004) Lipid and cholesterol trafficking in NPC. Biochim Biophys Acta 1685: 28-37.
31. Nagy, P.D., and Pogany, J. (2012) The dependence of viral RNA replication on co-opted host factors. Nat Rev Microbiol 10: 137-149.
32. Poh, M.K., Shui, G., Xie, X., Shi, P.Y., Wenk, M.R., and Gu, F. (2012) U18666A, an intra-cellular cholesterol transport inhibitor, inhibits dengue virus entry and replication. Antiviral Res 93: 191-198.
33. Reiss, S., Rebhan, I., Backes, P., Romero-Brey, I., Erfle, H., Matula, P., etal. (2011) Recruitment and activation of a lipid kinase by hepatitis C virus NS5A is essential for integrity of the membranous replication compartment. Cell Host Microbe 9: 32-45.
34. Rocha, N., Kuijl, C., van der Kant, R., Janssen, L., Houben, D., Janssen, H., etal. (2009) Cholesterol sensor ORP1L contacts the ER protein VAP to control Rab7-RILP-p150 Glued and late endosome positioning. J Cell Biol 185: 1209-1225.
35. Rothwell, C., Lebreton, A., Young Ng, C., Lim, J.Y., Liu, W., Vasudevan, S., etal. (2009) Cholesterol biosynthesis modulation regulates dengue viral replication. Virology 389: 8-19.
36. Roulin, P.S., Lötzerich, M., Torta, F., Tanner, L.B., van Kuppeveld, F.J.M., Wenk, M.R., and Greber, U.F. (2014) Rhinovirus uses a phosphatidylinositol 4-phosphate/cholesterol counter-current for the formation of replication compartments at the ER-golgi interface. Cell Host Microbe 16: 677-690.
37. Sagan, S.M., Rouleau, Y., Leggiadro, C., Supekova, L., Schultz, P.G., Su, A.I., and Pezacki, J.P. (2006) The influence of cholesterol and lipid metabolism on host cell structure and hepatitis C virus replication. Biochem Cell Biol 84: 67-79.
38. van der Schaar, H.M., van der Linden, L., Lanke, K.H., Strating, J.R., Purstinger, G., de Vries, E., etal. (2012) Coxsackievirus mutants that can bypass host factor PI4KIIIbeta and the need for high levels of PI4P lipids for replication. Cell Res 22: 1576-1592.
39. van der Schaar, H.M., Leyssen, P., Thibaut, H.J., de Palma, A., van der Linden, L., Lanke, K.H., etal. (2013) A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIbeta. Antimicrob Agents Chemother 57: 4971-4981.
40. Siljamäki, E., Rintanen, N., Kirsi, M., Upla, P., Wang, W., Karjalainen, M., etal. (2013) Cholesterol dependence of collagen and echovirus 1 trafficking along the novel alpha2beta1 integrin internalization pathway. PLoS ONE 8: e55465.
41. Strating, J., van der Linden, L., Albulescu, L., Bigay, J., Arita, M., Delang, L., etal. (2015) Itraconazole inhibits enterovirus replication by targeting the oxysterol-binding protein (OSBP). Cell Rep 10: 600-615.
42. Sugii, S., Lin, S., Ohgami, N., Ohashi, M., Chang, C.C., and Chang, T.Y. (2006) Roles of endogenously synthesized sterols in the endocytic pathway. J Biol Chem 281: 23191-23206.
43. Takahashi, M., Murate, M., Fukuda, M., Sato, S.B., Ohta, A., and Kobayashi, T. (2007) Cholesterol controls lipid endocytosis through Rab11. Mol Biol Cell 18: 2667-2677.
44. Wang, H., Perry, J.W., Lauring, A.S., Neddermann, P., De Francesco, R., and Tai, A.W. (2014) Oxysterol-binding protein is a phosphatidylinositol 4-kinase effector required for HCV replication membrane integrity and cholesterol trafficking. Gastroenterology 146: 1373-1385.
45. Wessels, E., Duijsings, D., Notebaart, R.A., Melchers, W.J., and van Kuppeveld, F.J. (2005) A proline-rich region in the coxsackievirus 3A protein is required for the protein to inhibit endoplasmic reticulum-to-golgi transport. J Virol 79: 5163-5173.
46. West, M., Zurek, N., Hoenger, A., and Voeltz, G.K. (2011) A 3D analysis of yeast ER structure reveals how ER domains are organized by membrane curvature. J Cell Biol 193: 333-346.
47. Wong, J., Zhang, J., Gao, G., Esfandiarei, M., Si, X., Wang, Y., etal. (2006) Liposome-mediated transient transfection reduces cholesterol-dependent coxsackievirus infectivity. J Virol Methods 133: 211-218.
48. Zidovetzki, R., and Levitan, I. (2007) Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768: 1311-1324.